Commentary, Int J Glob Health Vol: 8 Issue: 2

Coronary Artery Disease: Pathophysiology, Diagnosis, and Management

Balint Szilveszter ^*

Department of Cardiology, University of Semmelweis, Budapest, Városmajor Street, Hungary

*Corresponding Author: Balint Szilveszter,
Department of Cardiology, University of Semmelweis, Budapest, Városmajor Street, Hungary
E-mail:szilveszter.balint@univ.hu

Received: 16 August, 2024, Manuscript No. IJGH-24-145611;

Editor assigned: 20 August, 2024, PreQC No. IJGH-24-145611 (PQ);

Reviewed:03 September, 2024, QC No. IJGH-24-145611;

Revised: 15 April, 2025, Manuscript No. IJGH-24-145611 (R);

Published: 22 April, 2025, DOI: 10.4172/Ijgh.1000233.

Citation: Szilveszter B (2025) Coronary Artery Disease: Pathophysiology, Diagnosis, and Management. Int J Glob Health 8:2.

Description

Coronary Artery Disease (CAD) is a prevalent and significant cardiovascular condition characterized by the obstruction of coronary arteries due to atherosclerosis. This obstruction impairs blood flow to the heart muscle, leading to a range of symptoms from angina pectoris to Myocardial Infarction (MI) and even sudden cardiac death. This manuscript provides an overview of CAD, focusing on its pathophysiology, clinical presentation, diagnostic methods, and management strategies. CAD primarily arises from atherosclerosis, a process where fatty deposits (atheromas) build up on the arterial walls. The process begins with endothelial injury, which allows lipoproteins, particularly Low-Density Lipoprotein (LDL), to infiltrate the arterial wall. As LDL cholesterol accumulates, it undergoes oxidation, leading to an inflammatory response. This results in the recruitment of immune cells, such as macrophages, which engulf oxidized LDL and become foam cells. Over time, these cells accumulate, forming atherosclerotic plaques. Advanced plaques may rupture, exposing thrombogenic materials to the bloodstream and triggering platelet aggregation and thrombus formation. This thrombus can further occlude the artery, leading to reduced blood flow or complete blockage. Key modifiable risk factors for CAD include hypertension, hyperlipidemia, smoking, diabetes mellitus, and physical inactivity. Each of these factors contributes to the development and progression of atherosclerosis. Non-modifiable factors include age, gender, and genetic predisposition. Men generally have a higher risk at a younger age, but the risk for women increases and may surpass that for men post-menopause.

The most common symptom of CAD is chest pain or discomfort, known as angina pectoris. This pain may be described as pressure, squeezing, or heaviness and often occurs with exertion or emotional stress. A complete blockage of a coronary artery can lead to an MI, often characterized by severe chest pain, shortness of breath, nausea, and diaphoresis. MI may also present with atypical symptoms, particularly in women and elderly patients. Some individuals with CAD may experience silent ischemia, where the heart muscle is deprived of oxygen without producing noticeable symptoms. This condition is often detected through diagnostic tests rather than symptoms. Chronic CAD can lead to heart failure, where the heart becomes too weak to pump blood effectively. CAD increases the risk of arrhythmias, including ventricular tachycardia and atrial fibrillation, which can further complicate the disease and increase the risk of sudden cardiac death.

Diagnosis

Clinical evaluation

History and physical examination: A thorough patient history and physical examination are essential for diagnosing CAD. The history includes evaluating symptoms, risk factors, and family history of cardiovascular disease.

Electrocardiogram (ECG): An ECG records the electrical activity of the heart and can help identify ischemic changes, arrhythmias, or previous MI.

Stress testing: Stress tests, including exercise treadmill tests or pharmacologic stress tests, assess the heart’s response to increased workload and can reveal exercise-induced ischemia.

Imaging studies: Coronary angiography remains the gold standard for visualizing coronary artery occlusions. Non-invasive imaging techniques such as Computed Tomography Coronary Angiography (CTCA) and cardiac Magnetic Resonance Imaging (MRI) can also be used for diagnosis.

Biomarkers: Blood tests for cardiac biomarkers, such as troponin and Creatine Kinase-MB (CK-MB), are useful for diagnosing and assessing the severity of an MI.

Management strategies

Lifestyle modifications

Diet: A heart-healthy diet rich in fruits, vegetables, whole grains, and lean proteins, while low in saturated fats, cholesterol, and sodium, is essential for managing CAD.

Exercise: Regular physical activity, such as brisk walking or cycling, helps improve cardiovascular fitness, control weight, and reduce CAD risk.

Smoking cessation: Quitting smoking is one of the most impactful changes for reducing CAD risk and improving overall cardiovascular health.

Pharmacological treatment

Antiplatelet agents: Aspirin and other antiplatelet drugs, such as clopidogrel, reduce platelet aggregation and prevent thrombus formation, thus reducing the risk of MI and stroke.

Statins: Statins are used to lower LDL cholesterol levels and stabilize atherosclerotic plaques, reducing the risk of cardiovascular events.

Antihypertensives: Medications such as ACE inhibitors, betablockers, and calcium channel blockers help control blood pressure and reduce heart strain.

Antianginal agents: Nitrates, beta-blockers, and calcium channel blockers are used to relieve angina symptoms by improving blood flow and reducing myocardial oxygen demand.

Interventional procedures

Angioplasty and stenting: Percutaneous Coronary Interventions (PCI) such as balloon angioplasty and stenting are used to open blocked coronary arteries and restore blood flow.

Coronary Artery Bypass Grafting (CABG): CABG surgery involves creating new pathways for blood flow to the heart by grafting arteries or veins from other parts of the body, bypassing blocked coronary arteries.

Cardiac rehabilitation

Program components: Cardiac rehabilitation programs offer supervised exercise, education, and counseling to support recovery, improve functional capacity, and reduce the risk of future cardiovascular events.

Benefits: Participation in cardiac rehabilitation has been shown to improve cardiovascular outcomes, enhance quality of life, and support long-term adherence to lifestyle changes.

Conclusion

Coronary artery disease remains a major public health concern due to its high prevalence and significant impact on morbidity and mortality. Understanding its pathophysiology, recognizing its clinical manifestations, and utilizing advanced diagnostic and management strategies are crucial for effective treatment. Lifestyle modifications, pharmacological therapies, and interventional procedures play a key role in managing CAD, while ongoing research and technological advancements offer promise for improved outcomes and personalized care. By addressing risk factors, promoting preventive measures, and leveraging innovative treatments, we can enhance the quality of life for individuals affected by CAD and reduce the burden of this chronic condition.